CIS-话题@MedSci

#CIS#

58篇内容 | 883人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1993642, encodeId=67c61993642e5, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=ESC 2022：PCI对伴LV功能障碍患者血运重建无获益（REVIVED-BCIS2研究）, objectType=article, longId=737195, objectId=f379e37195f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f379e37195f4, replyNumber=0, likeNumber=46, createdTime=2023-02-17, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f379e37195f4, moduleTitle=ESC 2022：PCI对伴LV功能障碍患者血运重建无获益（REVIVED-BCIS2研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f379e37195f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993639, encodeId=d85f1993639ac, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=European Radiology：上尿路CIS的CT表现与诊断, objectType=article, longId=728752, objectId=1ac2e2875217, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ac2e2875217, replyNumber=0, likeNumber=35, createdTime=2022-12-18, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ac2e2875217, moduleTitle=European Radiology：上尿路CIS的CT表现与诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ac2e2875217)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993641, encodeId=49f0199364198, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=缺血性卒中分型搞不清？TOAST 分型与 CISS 分型有何区别, objectType=article, longId=733174, objectId=c4dae331747d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4dae331747d, replyNumber=0, likeNumber=46, createdTime=2022-12-02, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4dae331747d, moduleTitle=缺血性卒中分型搞不清？TOAST 分型与 CISS 分型有何区别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4dae331747d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993638, encodeId=49b21993638f3, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Thorac Cancer：真实世界中晚期NSCLC患者伴有KRAS、MET、FGFR、RET、BRAF和HER2改变时一线使用免疫检查点抑制剂(ICIs)的疗效, objectType=article, longId=727690, objectId=5f10e2769003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f10e2769003, replyNumber=0, likeNumber=36, createdTime=2022-07-16, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f10e2769003, moduleTitle=Thorac Cancer：真实世界中晚期NSCLC患者伴有KRAS、MET、FGFR、RET、BRAF和HER2改变时一线使用免疫检查点抑制剂(ICIs)的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f10e2769003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993635, encodeId=daaa1993635a6, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=双抗期间院外出血风险评估（PRECISE-DAPT score）, objectType=article, longId=300836, objectId=b71930083632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b71930083632, replyNumber=0, likeNumber=45, createdTime=2022-10-09, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b71930083632, moduleTitle=双抗期间院外出血风险评估（PRECISE-DAPT score）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b71930083632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993640, encodeId=9151199364032, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=诺华与 Precision合作开发潜在的镰状细胞性贫血基因治疗, objectType=article, longId=730268, objectId=6578e302681b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6578e302681b, replyNumber=0, likeNumber=0, createdTime=2022-08-24, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6578e302681b, moduleTitle=诺华与 Precision合作开发潜在的镰状细胞性贫血基因治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6578e302681b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993629, encodeId=511e199362974, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=N6-methyladenosine could indirectly modulate translation in human cancer cells via cis-elements, objectType=article, longId=220905, objectId=6600220905d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6600220905d0, replyNumber=0, likeNumber=34, createdTime=2022-02-02, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6600220905d0, moduleTitle=N6-methyladenosine could indirectly modulate translation in human cancer cells via cis-elements, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6600220905d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993630, encodeId=b71d1993630e0, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效, objectType=article, longId=220996, objectId=8ab722099677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab722099677, replyNumber=0, likeNumber=58, createdTime=2022-10-28, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab722099677, moduleTitle=Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab722099677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993636, encodeId=b7dc1993636a0, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Psychology of Sport and Exercise：仅30分钟运动，就能立即改善抑郁症患者的情绪, objectType=article, longId=723431, objectId=22e4e2343181, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22e4e2343181, replyNumber=0, likeNumber=41, createdTime=2023-03-11, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22e4e2343181, moduleTitle=Psychology of Sport and Exercise：仅30分钟运动，就能立即改善抑郁症患者的情绪, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22e4e2343181)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993626, encodeId=f276199362687, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响, objectType=article, longId=219336, objectId=97b7219336b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97b7219336b4, replyNumber=0, likeNumber=38, createdTime=2022-04-11, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97b7219336b4, moduleTitle=Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97b7219336b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993637, encodeId=cd92199363edb, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Radiology：可提示低核分化等级DCIS的影像学和病理学相关征象, objectType=article, longId=724048, objectId=a3c3e240481d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c3e240481d, replyNumber=0, likeNumber=39, createdTime=2022-06-04, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c3e240481d, moduleTitle=Radiology：可提示低核分化等级DCIS的影像学和病理学相关征象, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3c3e240481d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993633, encodeId=af8a19936332b, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效, objectType=article, longId=294112, objectId=1b49294112ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b49294112ae, replyNumber=0, likeNumber=60, createdTime=2022-11-25, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b49294112ae, moduleTitle=Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b49294112ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993631, encodeId=144919936314b, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation, objectType=article, longId=221060, objectId=69b22210602c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69b22210602c, replyNumber=0, likeNumber=31, createdTime=2022-05-12, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69b22210602c, moduleTitle=Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69b22210602c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993634, encodeId=9a831993634c6, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=iRECIST丨实体肿瘤免疫治疗疗效评价标准, objectType=article, longId=295557, objectId=9b1329555e86, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b1329555e86, replyNumber=0, likeNumber=41, createdTime=2022-02-24, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b1329555e86, moduleTitle=iRECIST丨实体肿瘤免疫治疗疗效评价标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b1329555e86)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993627, encodeId=c31b199362e35, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性, objectType=article, longId=220495, objectId=dbd22204957c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbd22204957c, replyNumber=0, likeNumber=35, createdTime=2022-09-19, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbd22204957c, moduleTitle=Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbd22204957c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993628, encodeId=60631993628ff, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Medicine ＆ Science in Sports ＆ Exercise：大规模研究显示，运动确实能防癌，但需要每周运动5小时以上, objectType=article, longId=218810, objectId=2f8c21881013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f8c21881013, replyNumber=0, likeNumber=43, createdTime=2022-02-07, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f8c21881013, moduleTitle=Medicine ＆ Science in Sports ＆ Exercise：大规模研究显示，运动确实能防癌，但需要每周运动5小时以上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f8c21881013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993632, encodeId=052519936322f, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=Cancer Immunol Immunother：免疫检查点抑制剂(ICIs)联合瑞戈非尼（regorafenib）治疗晚期或转移性微卫星稳定（MSS）结直肠癌的疗效和安全性, objectType=article, longId=292745, objectId=425c292e45ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=425c292e45ea, replyNumber=0, likeNumber=47, createdTime=2022-05-25, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=425c292e45ea, moduleTitle=Cancer Immunol Immunother：免疫检查点抑制剂(ICIs)联合瑞戈非尼（regorafenib）治疗晚期或转移性微卫星稳定（MSS）结直肠癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=425c292e45ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993624, encodeId=32f2199362455, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=npj Precision Oncology ：研究员发现了一种胰腺癌的生物标志物！, objectType=article, longId=213762, objectId=fd5e213e62ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd5e213e62ca, replyNumber=0, likeNumber=50, createdTime=2022-03-23, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd5e213e62ca, moduleTitle=npj Precision Oncology ：研究员发现了一种胰腺癌的生物标志物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd5e213e62ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993625, encodeId=95d9199362562, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=NEJM：长效单克隆抗体CIS43LS用于疟疾的预防, objectType=article, longId=215677, objectId=77c82156e78d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77c82156e78d, replyNumber=0, likeNumber=39, createdTime=2022-06-26, rootId=0, userName=12498ebem19暂无昵称, userId=3b172500206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77c82156e78d, moduleTitle=NEJM：长效单克隆抗体CIS43LS用于疟疾的预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77c82156e78d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993619, encodeId=7cd5199361950, content=<a href='/topic/show?id=17124e60f1' target=_blank style='color:#2F92EE;'>#CIS#</a>, objectTitle=礼来与Precision BioSciences合作进行基因组编辑研究, objectType=article, longId=203878, objectId=dfda2038e848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfda2038e848, replyNumber=0, likeNumber=42, createdTime=2021-02-14, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfda2038e848, moduleTitle=礼来与Precision BioSciences合作进行基因组编辑研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfda2038e848)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CIS

2020-05-29

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

ESC 2022：PCI对伴LV功能障碍患者血运重建无获益（REVIVED-BCIS2研究）

2023-02-17

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

European Radiology：上尿路CIS的CT表现与诊断

2022-12-18

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

缺血性卒中分型搞不清？TOAST 分型与 CISS 分型有何区别

2022-12-02

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Thorac Cancer：真实世界中晚期NSCLC患者伴有KRAS、MET、FGFR、RET、BRAF和HER2改变时一线使用免疫检查点抑制剂(ICIs)的疗效

2022-07-16

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

双抗期间院外出血风险评估（PRECISE-DAPT score）

2022-10-09

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

诺华与 Precision合作开发潜在的镰状细胞性贫血基因治疗

2022-08-24

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

N6-methyladenosine could indirectly modulate translation in human cancer cells via cis-elements

2022-02-02

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效

2022-10-28

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Psychology of Sport and Exercise：仅30分钟运动，就能立即改善抑郁症患者的情绪

2023-03-11

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响

2022-04-11

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Radiology：可提示低核分化等级DCIS的影像学和病理学相关征象

2022-06-04

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效

2022-11-25

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation

2022-05-12

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

iRECIST丨实体肿瘤免疫治疗疗效评价标准

2022-02-24

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性

2022-09-19

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Medicine ＆ Science in Sports ＆ Exercise：大规模研究显示，运动确实能防癌，但需要每周运动5小时以上

2022-02-07

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

Cancer Immunol Immunother：免疫检查点抑制剂(ICIs)联合瑞戈非尼（regorafenib）治疗晚期或转移性微卫星稳定（MSS）结直肠癌的疗效和安全性

2022-05-25

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

npj Precision Oncology ：研究员发现了一种胰腺癌的生物标志物！

2022-03-23

12498ebem19暂无昵称 (审核中...)

前往app查看评论内容

#CIS#

NEJM：长效单克隆抗体CIS43LS用于疟疾的预防

2022-06-26

docwu2019 (审核中...)

前往app查看评论内容

#CIS#

礼来与Precision BioSciences合作进行基因组编辑研究

2021-02-14

科室
- - 订阅+
  - 更多科室
工具
服务